Ovaphil-L

Ovaphil-L

Rs. 1,590.00
Skip to product information
Ovaphil-L
  • Ovaphil-L
Ovaphil-L

Ovaphil-L

We make things that work better and last longer. Our products solve real problems with clean design and honest materials.
Rs. 1,590.00
  • OBGYN RECOMMENDED
  • INGREDIENT TRANSPARENCY
    We have nothing to hide, and we proudly disclose every hand-selected ingredient.
FORMULATED WITH CLINICAL ACTIVES
  • Increase ovulation and pregnancy rates in PCOS compared to Clomiphene, with higher monofollicular development and better endometrial receptivity.
  • Lower incidence of multiple pregnancies due to single dominant follicle development, reducing twin and higher-order pregnancy-related problems
  • No anti-estrogenic effect on endometrial lining and cervical mucus, preserving their thickness and quality
  • Also effective in Clomiphene-resistant PCOS patients by passing blocked estrogen receptor sites

1 tablet once a day for 5 consecutive days, or as directed by your gynaecologist/physician.

Timing: Best initiated on Day 3 or Day 5 of your menstruation.

Duration: 5 days per cycle. Repeat cycles as directed by your gynaecologist/physician based on your response and as indicated by ultrasound evaluation of follicular growth.

Important: To be taken under medical supervision for ovulation induction, e.g., in PCOS patients. 

Letrozole 2.5 mg – Ovulation Induction

Ovaphil L (Letrozole 2.5 mg) successfully stimulates the ovulatory process by developing and releasing mature eggs. Therefore, letrozole is a more effective treatment than clomiphene in women who have polycystic ovary syndrome (PCOS) because it offers a significantly improved endometrial profile.

Ovaphil L, Ovaphil-L (Letrozole 2.5 mg) is a second-line drug in treating ovulation inducing in women with PCOS-related infertility, anovulation and unexplained infertility struggles. Ovaphil-L promotes the growth of healthy follicles, normal menstrual cycles, and improves the chance of natural conception. Gynecologists therefore widely consider Ovaphil-L a first-line treatment because of its similar high success rates, favorable safety profile and better endometrial response compared to other first-line treatments.

Ovaphil L is a scientifically designed ovulation induction treatment for anovulatory or abnormally ovulating women who are infertile, usually seen in Polycystic Ovary Syndrome (PCOS) or unexplained infertility. Each tablet contains Letrozole 2.5 mg, a non-steroidal aromatase inhibitor and a primary cause of ovulation induction.

Letrozole exerts its effect by inhibiting the action of the aromatase enzyme, hence reducing the amount of estrogen in the body. Short-term suppression of estrogen elicits a compensatory increase in follicle-stimulating hormone (FSH) secretion from the pituitary gland. Increased levels of FSH cause stimulation and development of ovarian follicles, thus leading to ovulation.

⚙️Mechanism of Action: 

  • Inhibits androgen conversion to estrogen through aromatase enzyme inhibition
  • Decreases estrogen-induced inhibition of the hypothalamic-pituitary axis
  • Promotes endogenous FSH release
  • Triggers growth of follicle in the ovary
  • Encourages timely ovulation

Indications:

  • Anovulatory infertility, especially in PCOS
  • Irregular ovulation cycles
  • Induction of primary ovulation in resistant patients to Clomiphene Citrate
  • Unexplained infertility in certain cases

To learn effective approaches to restoring vaginal balance, and addressing common issues like dryness or irritation, refer to our detailed guide: Read Now...

Frequently Asked Questions
When is the best time to take Ovaphil L during a cycle?

As directed, it is typically taken on days 2–6 or 3–7 of the menstrual cycle.
Does Ovaphil L increase the likelihood of getting pregnant?

Yes, it raises the chance of conception by causing ovulation.
Does Ovaphil L have any adverse effects?

Hot flashes, exhaustion, lightheadedness, or nausea are possible adverse effects.

You may also like